Prediction of Arterial Lactate and Blood Gas Values Through the Analysis of Central Venous Blood
Launched by CENTRE HOSPITALIER RÉGIONAL D'ORLÉANS · Aug 29, 2020
Trial Information
Current as of May 27, 2025
Completed
Keywords
ClinConnect Summary
Mathematical models for predicting arterial blood gas and arterial lactate have recently be published (PMID 27543529; see the citations section). The aim of the study is to externally validate these models in a multicenter (11 centres in France) cohort of intensive care unit patients suffering from acute circulatory failure. For the peru pose of the study, patients will undergo concomitent central venous/arterial blood sampling from 1 to 4 times during their intensive cafe unit stay. Clinical characteristics of the patients and central venous blood gas and lactate values will be used to pre...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • age\>18 years
- • patient admitted in a intensive care unit
- • patient already carrying an indwelling arterial catheter and a superior vena cava central catheter
- • patient presenting an acute circulatory failure defined by the presence of at least two of the following items: a) Persistent hypotension (systolic arterial blood pressure \< 90 mm Hg or mean arterial pressure \< 65 mm Hg) or need for continuous intravenous vasopressor treatment (at any dose). b) Presence of at least one of the following signs of hypoperfusionfusion :Change in mental status ; Skin mottling ; Oliguria (Urine output \<0.5 ml/kg body weight for at least one hour); Arterial lactate \> 2 mmol/l or peripheral venous lactate \> 3.2 mmol/l; ScvO2 \<70%.
- • Routine medical management requires central venous blood sampling for ScvO2 measurement and arterial blood sampling for gazometry.
- Exclusion Criteria:
- • Opposition to participation in the study
- • Impossibility to take a concomitant arterial and venous gazometric sample.
- • Patient treated with ECMO (extracorporeal membrane,oxygrnation), intermittent dialysis or continuous dialysis during sampling
- • Patient hospitalized without consent and/or deprived of liberty by court decision.
About Centre Hospitalier Régional D'orléans
The Centre Hospitalier Régional d'Orléans is a leading healthcare institution dedicated to advancing medical research and improving patient care through innovative clinical trials. Located in Orléans, France, the center is committed to fostering a collaborative environment that integrates clinical expertise with cutting-edge research methodologies. By facilitating multidisciplinary studies across various therapeutic areas, the Centre Hospitalier Régional d'Orléans aims to enhance treatment protocols and contribute to the global body of medical knowledge, ultimately benefiting patients and the healthcare community at large.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Nantes, , France
Marseille, , France
Angers, , France
Dijon, , France
Limoges, , France
Orléans, , France
Strasbourg, , France
Poitiers, , France
Garches, , France
Versailles, , France
Patients applied
Trial Officials
Toufik Kamel, MD
Principal Investigator
CHR Orléans, France
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials